Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: July 11, 2001
Last updated: June 19, 2013
Last verified: December 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2006
  Estimated Primary Completion Date: No date given